Search

This study compared the muscle and tendon morphology of an extraordinarily strong individual, a World's Strongest Man and deadlift champion (WSM), with that of various other athletic, trained, and untrained populations. The WSM completed the following: 1) 3.0-T MRI scans, to determine the volume of 22 individual lower limb muscles, 5 functional muscle groups, patellar tendon (PT) cross-sectional area (CSA), and PT moment arm; and 2) countermovement jumps (CMJ) and isometric midthigh pull (IMTP) contractions. The WSM was compared with previously assessed groups from our laboratory (muscle and tendon) and the wider research literature (CMJ and IMTP). The WSM's CMJ peak power (9,866 W) and gross (9,171 N) and net (7,480 N) IMTP peak forces were higher than any previously published values. The WSM's overall measured leg muscle volume was approximately twice that of untrained controls (+96%) but with pronounced anatomical variability in the extent of muscular development. The plantar flexor group (+120%) and the guy rope muscles (sartorius, gracilis, and semitendinosus: +140% to +202%), which stabilize the pelvis and femur, demonstrated the largest differences relative to that of untrained controls. The WSM's pronounced quadriceps size (greater than or equal to twofold vs. untrained) was accompanied by modest PT moment arm differences and, notably, was not matched by an equivalent difference in PT CSA (+30%). These results provide novel insight into the musculotendinous characteristics of an extraordinarily strong individual, which may be toward the upper limit of human variation, such that the WSM's very pronounced lower limb muscularity also exhibited distinct anatomical variability and with muscle size largely uncoupled from tendon size. NEW & NOTEWORTHY: Lower-body muscle size of an extraordinarily strong individual, a World's Strongest Man and deadlift champion (WSM), was approximately twice that of controls but was underpinned by pronounced anatomical variability in the extent of muscular development (+23–202%): the plantar flexor group and guy rope muscles demonstrating the largest differences. The WSM's quadriceps size (more than or equal to twice that of controls) contrasted with modest differences in patella tendon moment arm (+18%) and was uncoupled from patellar tendon size (+30%). [ABSTRACT FROM AUTHOR]

Aim: Bioactive collagen peptides (CP) have been suggested to augment the functional, structural (size and architecture), and contractile adaptations of skeletal muscle to resistance training (RT), but with limited evidence. This study aimed to determine if CP vs. placebo (PLA) supplementation enhanced the functional and underpinning structural, and contractile adaptations after 15 weeks of lower body RT. Methods: Young healthy males were randomized to consume either 15 g of CP (n = 19) or PLA (n = 20) once every day during a standardized program of progressive knee extensor, knee flexor, and hip extensor RT 3 times/wk. Measurements pre‐ and post‐RT included: knee extensor and flexor isometric strength; quadriceps, hamstrings, and gluteus maximus volume with MRI; evoked twitch contractions, 1RM lifting strength, and architecture (with ultrasound) of the quadriceps. Results: Percentage changes in maximum strength (isometric or 1RM) did not differ between‐groups (0.684 ≤ p ≤ 0.929). Increases in muscle volume were greater (quadriceps 15.2% vs. 10.3%; vastus medialis (VM) 15.6% vs. 9.7%; total muscle volume 15.7% vs. 11.4%; [all] p ≤ 0.032) or tended to be greater (hamstring 16.5% vs. 12.8%; gluteus maximus 16.6% vs. 12.9%; 0.089 ≤ p ≤ 0.091) for CP vs. PLA. There were also greater increases in twitch peak torque (22.3% vs. 12.3%; p = 0.038) and angle of pennation of the VM (16.8% vs. 5.8%, p = 0.046), but not other muscles, for CP vs. PLA. Conclusions: CP supplementation produced a cluster of consistent effects indicating greater skeletal muscle remodeling with RT compared to PLA. Notably, CP supplementation amplified the quadriceps and total muscle volume increases induced by RT. [ABSTRACT FROM AUTHOR]

Biceps femoris long head (BF LH ) aponeurosis size was compared between legs with and without prior hamstring strain injury (HSI) using two approaches: within-group (injured vs. uninjured legs of previous unilateral HSI athletes) and between-group (previously injured legs of HSI athletes vs. legs of No Prior HSI athletes). MRI scans were performed on currently healthy, competitive male athletes with Prior HSI history ( n =23;≥1 verified BF LH injury; including a sub-group with unilateral HSI history; most recent HSI 1.6±1.2 years ago) and pair-matched athletes with No Prior HSI history ( n =23). Anonymized axial images were manually segmented to quantify BF LH aponeurosis and muscle size. Prior unilateral HSI athletes' BF LH aponeurosis maximum width, aponeurosis area, and aponeurosis:muscle area ratio were 14.0-19.6% smaller in previously injured vs. contralateral uninjured legs (paired t-test, 0.008≤P≤0.044). BF LH aponeurosis maximum width and area were also 9.4-16.5% smaller in previously injured legs ( n =28) from Prior HSI athletes vs. legs ( n =46) of No Prior HSI athletes (unpaired t-test, 0.001≤P≤0.044). BF LH aponeurosis size was smaller in legs with prior HSI vs. those without prior HSI. These findings suggest BF LH aponeurosis size, especially maximum width, could be a potential cause or consequence of HSI, with prospective evidence needed to support or refute these possibilities., Competing Interests: The authors declare that there is no conflict of interest and that the results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation., (Thieme. All rights reserved.)